West Pharmaceutical Services Aktie
WKN: 864330 / ISIN: US9553061055
24.07.2025 12:37:39
|
West Pharmaceutical Services Inc. Q2 Profit Increases, Beats Estimates
(RTTNews) - West Pharmaceutical Services Inc. (WST) revealed a profit for its second quarter that Increased from the same period last year and beat the Street estimates.
The company's earnings totaled $131.8 million, or $1.82 per share. This compares with $111.3 million, or $1.51 per share, last year.
Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $133.5 million or $1.84 per share for the period.
Analysts on average had expected the company to earn $1.51 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 9.2% to $766.5 million from $702.1 million last year.
West Pharmaceutical Services Inc. earnings at a glance (GAAP) :
-Earnings: $131.8 Mln. vs. $111.3 Mln. last year. -EPS: $1.82 vs. $1.51 last year. -Revenue: $766.5 Mln vs. $702.1 Mln last year.
-Guidance: Full year EPS guidance: $6.65 - $6.85 Full year revenue guidance: $3.04 - $3.06B

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu West Pharmaceutical Services Inc.mehr Nachrichten
Analysen zu West Pharmaceutical Services Inc.mehr Analysen
Aktien in diesem Artikel
West Pharmaceutical Services Inc. | 231,50 | 0,70% |
|